These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 343554)

  • 21. [Antiphlogistic effect of salicylic acid and its derivatives].
    Binder M; Zeiller P
    Fortschr Med; 1993 Nov; 111(33):530-2. PubMed ID: 8307537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of salicylates on intestinal secretion in calves given (intestinal loops) Escherichia coli heat-stable enterotoxin.
    Wise CM; Knight AP; Lucas MJ; Morris CJ; Ellis RP; Phillips RW
    Am J Vet Res; 1983 Dec; 44(12):2221-5. PubMed ID: 6362497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of etersalate on human platelet responsiveness. A study in healthy volunteers.
    Ortega MP; Sunkel C; Armijo M; Priego JG
    Arzneimittelforschung; 1987 Feb; 37(2):214-7. PubMed ID: 2883981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 4-trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappaB activation.
    Bayón Y; Alonso A; Sánchez Crespo M
    Br J Pharmacol; 1999 Mar; 126(6):1359-66. PubMed ID: 10217529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of platelet 5-HT secretion and of 5-HT induced vasoconstriction by paracetamol.
    Verheggen R; Schrör K
    Prog Clin Biol Res; 1987; 242():271-6. PubMed ID: 3671387
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hypoglycemic properties of salicylates].
    Kovać T
    Med Pregl; 1968; 21(11):501-6. PubMed ID: 5715690
    [No Abstract]   [Full Text] [Related]  

  • 27. Are all aspirins really alike? A comparison of gastric ulcerogenicity with bio-efficacy in rats.
    Rainsford KD; Whitehouse MW
    Pharmacol Res Commun; 1980 Jan; 12(1):85-95. PubMed ID: 6966802
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet antiaggregatory effect of triflusal in human whole blood.
    de la Cruz JP; Pavia J; Bellido I; González MC; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):273-7. PubMed ID: 3386335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reduced ulcerogenic effect after treatment with indomethacin combined with diflunisal in rats].
    Conti P; Continenza MA; Cifone MG; Bruno G; Alesse E
    Boll Soc Ital Biol Sper; 1980 Apr; 56(8):833-8. PubMed ID: 7448080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The preventive effect of low-dose aspirin in the development of stress ulceration in rats.
    Kumashiro R; Montgomery O; Langman A; Kholoussy AM; Matsumoto T
    Am Surg; 1983 Aug; 49(8):423-7. PubMed ID: 6614664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consideration of platelet effects in the selection of an anti-inflammatory agent.
    Small RE; Johnson SM
    Clin Pharm; 1987 Oct; 6(10):756-7. PubMed ID: 3505838
    [No Abstract]   [Full Text] [Related]  

  • 32. A pharmacological analysis of aspirin.
    Collier HO
    Adv Pharmacol (1962); 1969; 7():333-405. PubMed ID: 4984754
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.
    Wallace JL; McKnight W; Del Soldato P; Baydoun AR; Cirino G
    J Clin Invest; 1995 Dec; 96(6):2711-8. PubMed ID: 8675638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proceedings: Inhibition of human platelet aggregation by aspirin in vitro and ex vivo.
    Gordon JL; Macintyre DE
    Br J Pharmacol; 1974 Nov; 52(3):451P. PubMed ID: 4458864
    [No Abstract]   [Full Text] [Related]  

  • 35. Gastric ulceration and the concentration of salicylate in plasma in rats after administration of 14C-labelled aspirin and its synthetic triglyceride, 1,3-dipalmitoyl-2(2'-acetoxy-[14C]carboxylbenzoyl) glycerol.
    Kumar R; Billimoria JD
    J Pharm Pharmacol; 1978 Dec; 30(12):754-8. PubMed ID: 32238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of copper-aspirin complex on platelet aggregation.
    Shen ZQ; Chen ZH; Ma GY; Wang DC; Wu WL; Liu WP; Yang YK; Xiong HZ
    Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):358-62. PubMed ID: 10072923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salicylate inhibition of antiplatelet effect of aspirin.
    Brantmark B; Hedner U; Melander A; Wåhlin-Boll E
    Lancet; 1981 Dec; 2(8259):1349. PubMed ID: 6118746
    [No Abstract]   [Full Text] [Related]  

  • 38. Salicylic acid biosynthesis and its control in Mycobacterium smegmatis.
    Marshall BJ; Ratledge C
    Biochim Biophys Acta; 1972 Mar; 264(1):106-16. PubMed ID: 4623285
    [No Abstract]   [Full Text] [Related]  

  • 39. 2,3-Dihydroxybenzoate as a bacterial growth factor and its route of biosynthesis.
    Young IG; Cox GB; Gibson F
    Biochim Biophys Acta; 1967 Jul; 141(2):319-31. PubMed ID: 4292725
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacology of the hexylcarbonate of salicylic acid.
    Misher A; Adams HJ; Fishler JJ; Jones RG
    J Pharm Sci; 1968 Jul; 57(7):1128-31. PubMed ID: 5662048
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.